These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Critical appraisal of antileukotriene use in asthma management. Polosa R Curr Opin Pulm Med; 2007 Jan; 13(1):24-30. PubMed ID: 17133121 [TBL] [Abstract][Full Text] [Related]
3. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment]. Fal AM; Kopeć A Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521 [TBL] [Abstract][Full Text] [Related]
5. Review of recent results of montelukast use as a monotherapy in children with mild asthma. Wahn U; Dass SB Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists. Currie GP; Srivastava P; Dempsey OJ; Lee DK QJM; 2005 Mar; 98(3):171-82. PubMed ID: 15728398 [TBL] [Abstract][Full Text] [Related]
7. [Antileukotriene drugs in the treatment of obstructive lung diseases and rhinitis]. Mastalerz L; Kania A Pneumonol Alergol Pol; 2010; 78(1):74-8. PubMed ID: 20162522 [TBL] [Abstract][Full Text] [Related]
8. Advances in therapy with antileukotriene drugs. Riccioni G; Di Ilio C; Conti P; Theoharides TC; D'Orazio N Ann Clin Lab Sci; 2004; 34(4):379-87. PubMed ID: 15648777 [TBL] [Abstract][Full Text] [Related]
9. [Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors]. Diamant Z; Sterk PJ Ned Tijdschr Geneeskd; 1998 Jan; 142(5):72-8. PubMed ID: 12013053 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis. Virchow JC; Bachert C Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955 [TBL] [Abstract][Full Text] [Related]
11. Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma. Spahr JE; Krawiec ME Expert Opin Drug Saf; 2004 May; 3(3):173-85. PubMed ID: 15155146 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of response to asthma controller therapy: clinical implications. Langmack EL; Martin RJ Curr Opin Pulm Med; 2010 Jan; 16(1):13-8. PubMed ID: 19875959 [TBL] [Abstract][Full Text] [Related]
13. Montelukast: new preparation. No current use in asthma. Prescrire Int; 1999 Oct; 8(43):131-4. PubMed ID: 11503835 [TBL] [Abstract][Full Text] [Related]
14. [Churg-Strauss syndrome after treatment with Singulair (montelukast)]. Hammer HB; Aukrust P; Frøland SS Tidsskr Nor Laegeforen; 2002 Feb; 122(5):484-6. PubMed ID: 11961976 [TBL] [Abstract][Full Text] [Related]
16. Antileukotrienes in the treatment of asthma and allergic rhinitis. Ribeiro JD; Toro AA; Baracat EC J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S213-21. PubMed ID: 17136298 [TBL] [Abstract][Full Text] [Related]
17. [Leukotrienes and asthma. Clinical and experimental experiences with leukotriene receptor antagonists and leukotriene synthesis inhibitors]. Henriksen AH; Bjermer L Tidsskr Nor Laegeforen; 1997 Feb; 117(5):647-51. PubMed ID: 9102953 [TBL] [Abstract][Full Text] [Related]
18. Antileukotrienes: an emerging generation of drug therapies for asthma. Issues Emerg Health Technol; 1998 Apr; (3):1-5. PubMed ID: 11811210 [TBL] [Abstract][Full Text] [Related]
19. Management of asthma in preschool children with inhaled corticosteroids and leukotriene receptor antagonists. Bacharier LB Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):158-62. PubMed ID: 18317026 [TBL] [Abstract][Full Text] [Related]